Drug-drug interactions of protein kinase inhibitors in chronic myeloid leukaemia patients: a study using the French health insurance database.

Marie Pajiep Maryse Lapeyre MestreFabien Despas

Published in: Fundamental & clinical pharmacology (2023)

These findings should increase awareness to help reduce the prevalence of PKI-drug interactions, and thereby ensure better management of CML patients.

Keyphrases

end stage renal disease
health insurance
ejection fraction
chronic kidney disease
newly diagnosed
emergency department
peritoneal dialysis
acute myeloid leukemia
immune response
bone marrow
dendritic cells
patient reported